设为首页 加入收藏

TOP

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase](二十四)
2016-05-23 03:12:44 来源: 作者: 【大 中 小】 浏览:17491次 评论:0条
a rapid motion straight into the skin at a 90 degree angle. Tape needle in place with sterile tape.
•
Repeat this step if you have a second infusion site.
•
Check for proper needle placement by pulling back on the syringe plunger to check for blood return in the tubing of the needle set.
•
If blood is seen in the tubing, remove and discard the subcutaneous needle and repeat steps 3, 5 and 6 with a new subcutaneous needle and infusion site.
•
Secure the needle set in place by applying a sterile protective dressing over the site. If more than one site is used, repeat the steps
1.
Administer the hyaluronidase (Labeled as “HY”):
•
Administer the HY at an initial rate per infusion site of approximately 1 to 2 mL per minute and increase as tolerated. Divide the contents equally between sites, if more than one site is used.
•
Remove the syringe from the needle set, after infusing all of the content of the syringe.
•
Attach the pump tubing or syringe filled with the IG to the same needle set.  
1.
Administer the immune globulin (Labeled as “IG”:
Within 10 minutes of completing the infusion of the HY, start the pump to administer the IG.

•
Flush infusion tubing up to the needle hub with normal saline or Dextrose 5% in water (D5W) at the end of infusion, if directed by your healthcare professional.  
1.
Remove subcutaneous needle(s) from the infusion site(s):
•
Remove the needle set by loosening the tape on all edges.
•
Pull the needle wings straight up and out.
•
Gently press a small piece of gauze over the needle site and cover with a dressing.
•
Throw away the needle(s) into the sharps container.  
1.
Record the infusion:
•
Remove the peel-off label from HYQVIA vial(s), which has the product lot number and expiration date, and place the label in your treatment record/ infusion log
•
Write down the date, time, dose, site(s) of infusion (to assist in rotating sites) and any reactions after each infusion.
•
Throw away the disposable supplies, vials, and unused product as recommended by your healthcare professional.  
Baxalta and Hyqvia are trademarks of Baxalta Incorporated.

Patented: please see www.baxalta.com/productpatents/

Baxalta US Inc.

Westlake Village, CA 91362 USA

U.S. License No. 2020

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Recombinant Human Hyaluronidase 1.25 mL Infuse 1st Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
1.25 mL
160 units per mL

Lot/Expiry date:

Recombinant Human Hyaluronidase 2.5 mL Infuse 1st Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
2.5 mL
160 units per mL

Lot:
Expiry date:

Recombinant Human Hyaluronidase 5 mL Infuse 1st Vial Label

Recombinant Human Hyaluronidase

Component of HYQVIA
Infuse 1st
Single-Use Vial
Rx Only
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
5 mL
160 units per mL

Lot:
Expiry date:
 
Recombinant Human Hyaluronidase 10 mL Infuse 1st Vial Label

Recombinant Human Hyaluronida

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 21 22 23 24 25 26 27 下一页 尾页 24/30/30
【大 中 小】【打印】 【繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部】
分享到QQ空间
分享到: 
上一篇:IMURAN(azathioprine)Tablets 下一篇:ORTHO-CYCLEN ® and ORTHO TR..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位